Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis

Research output: Contribution to journal › Comment/Letter to the editor › Academic

5 Citations (Scopus)

Original language	English
Pages (from-to)	257-258
Journal	British Journal of Dermatology
Volume	159
Issue number	1
DOIs	https://doi.org/10.1111/j.1365-2133.2008.08606.x
Publication status	Published - 2008

Access to Document

@article{ba1e503c753648a79b05d39494f6b918,

title = "Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis",

author = "T. Nijsten and Spuls, {P. I.}",

year = "2008",

doi = "https://doi.org/10.1111/j.1365-2133.2008.08606.x",

language = "English",

volume = "159",

pages = "257--258",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis

AU - Nijsten, T.

AU - Spuls, P. I.

PY - 2008

Y1 - 2008

U2 - https://doi.org/10.1111/j.1365-2133.2008.08606.x

DO - https://doi.org/10.1111/j.1365-2133.2008.08606.x

M3 - Comment/Letter to the editor

C2 - 18489593

SN - 0007-0963

VL - 159

SP - 257

EP - 258

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 1

ER -